Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LLP/MLP Block vs Wound Infiltration for Postoperative Analgesia in Lumbar Spine Surgery
NCT07681648Phase 4Enrolling by invitation
- Sponsor
- Engy Emil
- Start
- Jul 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Engy Emil. Primary endpoint: Visual Analogue Scale for Pain Intensity at 48 hours. Started Jul 2026; status: enrolling by invitation.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07681648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07681648.